Industry
The combination of biological innovation and pharmaceutical muscle could create a unique pathway for translating microbiome discoveries into accessible, science-backed solutions for everyday health.
New funding boosts development of microbiome-based therapies for hereditary cancer risk, opening paths to alternatives beyond surgery.
The Bill & Melinda Gates Foundation accelerates research and innovation targeting the most neglected areas of female health.
With a strategic loan from the European Investment Bank, the French biotech doubles down on its mission to bring microbiome ecosystem therapies to market for patients battling blood cancers.
A unique partnership between Yakult and Nature Portfolio to build a global community of microbiome pioneers.
Industry
Sponsored by
dsm-firmenich Italy successfully hosts its first exclusive event on biotics.
Xervyteg® marks a major advance in microbiome therapeutics, with potential to become the first approved microbiota therapy in Europe.
Industry, Video
Sponsored by
Carlo Sala, Sales Director EMEA & LATAM - Microbiome BU at Sacco System, discusses the company innovative probiotic strains, tailored manufacturing services, and commitment to R&D.
Danone has announced the acquisition of The Akkermansia Company (TAC), significantly expanding its investment into gut health and next-generation biotic research.
Industry
Sponsored by
An interview to SynBalance Marketing Manager, Silva Castegnaro on the latest clinically backed solutions shaping the future of biotics world.
